Page 1 | Search Results | Blood | American Society of Hematology

1-7 of 7

Sort by

Sort Order Select

Journal Articles

Differential Diagnosis Distinguishing Immune TTP from Septic DIC Using Plasma Levels of Haptoglobin and Factor XIII Activity

Shinya Yamada, Masayuki Kubo, Eriko Hamada, Kenki Saito, Masaki Hayakawa, Hidesaku Asakura, Masanori Matsumoto

Blood (2022) 140 (Supplement 1): 2765–2766.

https://doi.org/10.1182/blood-2022-158126

Published: 2022

Journal Articles

The Efficacy and Safety of Caplacizumab in Japanese Patients with Immune-Mediated Thrombotic Thrombocytopenic Purpura (iTTP): An Open-Label, Phase 2/3 Study

Yoshitaka Miyakawa, Kazunori Imada, Satoshi Ichikawa, Hitoji Uchiyama, Yasunori Ueda, Akihito Yonezawa, Shigeki Fujitani, Hiroshi Handa, Tadashi Matsushita, Hidesaku Asakura, Kenji Nishio, Kodai Suzuki, Yasuhiro Hashimoto, Shinobu Ohshima, Sayaka Tahara, Tomoyuki Tanaka, Masanori Matsumoto

Blood (2021) 138 (Supplement 1): 1009.

https://doi.org/10.1182/blood-2021-148427

Published: 2021

Journal Articles

Effects of Fluvastatin on the Expression of Tissue Factor Pathway Inhibitor in Human Umbilical Vein Endothelial Cells

Keiko Maruyama, Eriko Morishita, MD, PhD, Hiroki Torishima, Akiko Sekiya, Hidesaku Asakura, MD, PhD, Shigeki Ohtake, MD, PhD, Shinji Nakao, MD, PhD

Blood (2011) 118 (21): 2253.

https://doi.org/10.1182/blood.V118.21.2253.2253

Published: 2011

Journal Articles

Curcumin Prevents Cytokine-Mediated Tissue Factor Pathway Inhibitor Down-Regulation in Human Endothelial Cells

Keiko Maruyama, Eriko Morishita, MD, PhD, Yukie Goto, Akiko Sekiya, Hidesaku Asakura, MD, PhD, Shigeki Ohtake, MD, PhD, Shinji Nakao, MD, PhD

Blood (2011) 118 (21): 1202.

https://doi.org/10.1182/blood.V118.21.1202.1202

Published: 2011

Journal Articles

Curcumin Down-Regulates Cytokine-Mediated Tissue Factor and Plasminogen Activator Type 1 Expression In Human Endothelial Cells

Eriko Morishita, MD, PhD, Keiko Maruyama, Hidesaku Asakura, MD, PhD, Shigeki Ohtake, MD, PhD, Akihiro Yachie, MD, PhD, Shinji Nakao, MD, PhD

Blood (2010) 116 (21): 3333.

https://doi.org/10.1182/blood.V116.21.3333.3333

Published: 2010

Journal Articles

Combined Antithrombotic Therapy but Not Single-Agent Therapy with Low-Dose Aspirin Deteriorated Platelet Activation in Patients with Antiphospholipid Syndrome (APS).

Masahide Yamazaki, MD, Yasuko Kadohira, Ph.D, Eriko Morishita, MD, Hidesaku Asakura, MD, Shinji Nakao, MD

Blood (2007) 110 (11): 4002.

https://doi.org/10.1182/blood.V110.11.4002.4002

Published: 2007

Journal Articles

Efficacy and Safety of Recombinant Human Soluble Thrombomodulin (ART-123) in Disseminated Intravascular Coagulation (DIC): Results of Phase III Randomized, Double-Blind, Clinical Trial.

Hidehiko Saito, MD, Ikuro Maruyama, MD, Shuji Shimazaki, MD, Yasuhiro Yamamoto, MD, Naoki Aikawa, MD, FACS, Ryuzo Ohno, MD, Akio Hirayama, MD, Tamotsu Matsuda, MD, Hidesaku Asakura, MD, Mitsuyoshi Nakashima, MD, Nobuo Aoki, MD

Blood (2006) 108 (11): 576.

https://doi.org/10.1182/blood.V108.11.576.576

Published: 2006

NARROW

Differential Diagnosis Distinguishing Immune TTP from Septic DIC Using Plasma Levels of Haptoglobin and Factor XIII Activity

The Efficacy and Safety of Caplacizumab in Japanese Patients with Immune-Mediated Thrombotic Thrombocytopenic Purpura (iTTP): An Open-Label, Phase 2/3 Study

Effects of Fluvastatin on the Expression of Tissue Factor Pathway Inhibitor in Human Umbilical Vein Endothelial Cells

Curcumin Prevents Cytokine-Mediated Tissue Factor Pathway Inhibitor Down-Regulation in Human Endothelial Cells

Curcumin Down-Regulates Cytokine-Mediated Tissue Factor and Plasminogen Activator Type 1 Expression In Human Endothelial Cells

Combined Antithrombotic Therapy but Not Single-Agent Therapy with Low-Dose Aspirin Deteriorated Platelet Activation in Patients with Antiphospholipid Syndrome (APS).

Efficacy and Safety of Recombinant Human Soluble Thrombomodulin (ART-123) in Disseminated Intravascular Coagulation (DIC): Results of Phase III Randomized, Double-Blind, Clinical Trial.

Email alerts

ASH Publications

American Society of Hematology

Differential Diagnosis Distinguishing Immune TTP from Septic DIC Using Plasma Levels of Haptoglobin and Factor XIII Activity

The Efficacy and Safety of Caplacizumab in Japanese Patients with Immune-Mediated Thrombotic Thrombocytopenic Purpura (iTTP): An Open-Label, Phase 2/3 Study

Effects of Fluvastatin on the Expression of Tissue Factor Pathway Inhibitor in Human Umbilical Vein Endothelial Cells

Curcumin Prevents Cytokine-Mediated Tissue Factor Pathway Inhibitor Down-Regulation in Human Endothelial Cells

Curcumin Down-Regulates Cytokine-Mediated Tissue Factor and Plasminogen Activator Type 1 Expression In Human Endothelial Cells

Combined Antithrombotic Therapy but Not Single-Agent Therapy with Low-Dose Aspirin Deteriorated Platelet Activation in Patients with Antiphospholipid Syndrome (APS).

Efficacy and Safety of Recombinant Human Soluble Thrombomodulin (ART-123) in Disseminated Intravascular Coagulation (DIC): Results of Phase III Randomized, Double-Blind, Clinical Trial.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only